Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Expert Reviews in Molecular Medicine|October 31, 2003
Grb7-based molecular therapeutics in cancerStephanie C Pero, Roger J Daly, David N KragJournal of Immunological Methods|December 9, 2019
A cocktail of polyclonal affinity enriched antibodies against melanoma mutations increases binding and inhibits tumor growthGirja S Shukla, Yu-Jing Sun, Stephanie C Pero, et al.Journal of Immunological Methods|June 23, 2009
Phage-display selection on tumor histological specimens with laser capture microdissectionYujing Sun, Girja S Shukla, Donald Weaver, et al.Biotechniques|August 27, 2015
Single tumor imaging with multiple antibodies targeting different antigensYujing Sun, Girja Shukla, Stephanie C Pero, et al.Journal of Immunological Methods|September 29, 2022
Targeting of palpable B16-F10 melanoma tumors with polyclonal antibodies on white blood cellsGirja S Shukla, Stephanie C Pero, Linda Mei, et al.Journal of Immunological Methods|June 16, 2018
Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine-draining lymph node B cell responsesGirja S Shukla, Yu-Jing Sun, Stephanie C Pero, et al.Biotechnology Progress|November 10, 2009
Identification of single chain antibodies to breast cancer stem cells using phage displayDeniz Gur, Suling Liu, Anurag Shukla, et al.Breast Cancer Research and Treatment|October 19, 2011
GRB7 is required for triple-negative breast cancer cell invasion and survivalOrsi Giricz, Verónica Calvo, Stephanie C Pero, et al.Journal of the National Cancer Institute|April 6, 2006
Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasisShinji Tanaka, Stephanie C Pero, Kenichi Taguchi, et al.Journal of Immunological Methods|February 1, 2018
Characterization of sentinel node-derived antibodies from breast cancer patientsGirja S Shukla, Stephanie C Pero, Yu-Jing Sun, et al.Pageof 4